Skip to main content

Market Overview

J.P. Morgan Maintains Rating, PT On CI

Share:

J.P. Morgan is maintaining its Overweight rating and its $55 price target on CIGNA Corp. (NYSE: CI) following meetings with the company's management.

In its report, J.P. Morgan writes, “We recently held meetings with management. Overall, still an emphasis on the global focus/nature of the CI business, while also specifically noting good traction in the core domestic health benefits segment (this 60% of earnings), with the 2012 large/jumbo account selling season entering final stages. Here the company sees considerably increased large employer focus this season on benefit designs which incorporate much higher levels of employee engagement and a view that this changing preference (or growing acceptance) plays well into their strengths. There also continues to be considerable attention that “disruptive” market changes – regulatory, competitive and heightened transparency – are creating opportunities for the company to move deeper into segments in which it currently has a minimal footprint, with much less at stake in terms of legacy earnings/share to protect. In short: likes its current positioning, still sees considerable growth potential, both domestic and international, and while understandably not definitive, somewhat downplaying the characterization of recent consolidation talk.”

CI closed yesterday at $49.22.

 

Related Articles (CI)

View Comments and Join the Discussion!

Posted-In: Cigna Corp. J.P. MorganAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com